Jump to Section: About aHUS | Special Events | Clinical Information | Networks and Support | Patient Materials & Resources |aHUS Global Advocate: NEWSLETTER |aHUS alliance Global Action | aHUS…
Global Action will be attending the Foundation’s Baltimore aHUS patients conference from the 28th to the 30th April. Here you will find out about the events and the people we…
WWW.AHUSALLIANCEGLOBALACTION.ORG 18 March 2023 aHUS PATIENTS' VIEWS ON THE ATTRIBUTION OF ADVERSE EVENTS /SIDE EFFECTS EXPERIENCED DUE TO EITHER THEIR PRIMARY DISEASE OR ITS TREATMENT Amber, Amelie, Amy, Anne-Kathrin, Arthur,…
Jump to Section: About aHUS | Special Events | Clinical Information | Networks and Support | Patient Materials (to Print & Share) |aHUS Global Advocate: NEWSLETTER |aHUS alliance Global Action…
To answer some of the questions in the aHUS Patients Research Agenda clinical trials will be needed. Take the issue of withdrawal from complement inhibitor treatment. Setting up a trial…
Fund raising, which began when aHUSUK still existed, has been put to use to help fund research which may improve the aHUS diagnosis process. Readers of this website may have…
We’re pleased to feature this interview with Dr Brad Lewis, Medical Director of Machaon Diagnostics. A hematologist with background in biochemistry and focus on thrombosis and hemostasis, Dr Lewis lectures…
Ravulizumab is eculizumab, Carsten. They work the same way. It is the same monoclonal antibody. It has just been modified in a couple of places so that it is effective…